Global Hyperthermic Intraperitoneal Chemotherapy Equipment Market Strategic Research Report

Scope of the Report

The global Hyperthermic Intraperitoneal Chemotherapy Equipment market size is predicted to grow from US$ 44.17 million in 2025 to US$ 62.21 million in 2032; it is expected to grow at a CAGR of 5.0% from 2026 to 2032.

Hyperthermic Intraperitoneal Chemotherapy Equipment is a specialized medical perfusion system used to deliver heated chemotherapy drugs directly into the abdominal cavity during or after cytoreductive surgery. The equipment typically includes a heating unit, circulation pump, temperature monitoring system, fluid reservoir, tubing set, heat exchanger, and safety control components, allowing chemotherapy solution to be warmed and continuously circulated within the peritoneal cavity at a controlled temperature. By combining localized drug delivery with hyperthermia, the system is designed to increase chemotherapy exposure to residual cancer cells while limiting systemic toxicity. It is mainly used in specialized oncology centers for selected patients with peritoneal malignancies, such as peritoneal metastases from colorectal, ovarian, gastric, or appendiceal cancers, as well as peritoneal mesothelioma. The price of the main unit for Hyperthermic Intraperitoneal Chemotherapy equipment typically ranges from approximately US$70,000 to US$150,000 per unit.

The upstream supply chain for Hyperthermic Intraperitoneal Chemotherapy Equipment mainly includes medical-grade pumps, heat exchangers, temperature sensors, pressure monitoring components, control systems, tubing sets, reservoirs, filters, sterile disposable kits, and biocompatible materials that meet medical device standards. Key manufacturing capabilities are concentrated in fluid temperature control, stable perfusion flow, real-time monitoring, sterility assurance, and system safety design. Downstream demand mainly comes from hospitals, cancer centers, surgical oncology departments, and specialized HIPEC treatment centers, where the equipment is used during cytoreductive surgery to circulate heated chemotherapy solution within the abdominal cavity. Market demand is closely linked to the clinical adoption of HIPEC procedures, hospital investment in oncology surgery capabilities, availability of trained surgical teams, and the recurring use of disposable procedure kits for each treatment.

The Hyperthermic Intraperitoneal Chemotherapy Equipment market is expected to grow steadily, driven by the increasing adoption of cytoreductive surgery combined with HIPEC in specialized oncology centers for selected peritoneal malignancies. However, this remains a niche and highly specialized equipment market rather than a broad hospital device category, as demand is concentrated in tertiary hospitals, cancer centers, and experienced surgical teams. Market growth is mainly supported by the expansion of HIPEC-capable centers, rising clinical awareness, and recurring demand for disposable procedure kits, while capital equipment sales are relatively limited due to the long replacement cycle of the systems. Competition is likely to focus on temperature control accuracy, perfusion stability, ease of operation, safety monitoring, disposable kit availability, and clinical service support. Overall, the market should maintain moderate growth, but its scale will remain constrained by procedure complexity, strict patient selection, high dependence on trained surgical teams, and the limited number of institutions able to perform HIPEC regularly.

This report presents a comprehensive overview of the global Hyperthermic Intraperitoneal Chemotherapy Equipment market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Integrated HIPEC Systems
• Modular HIPEC Systems

Segment by Perfusion Method

• Open HIPEC System
• Closed HIPEC System
• Hybrid HIPEC System

Segment by Temperature Control Range

• Standard Temperature Control (37–43°C)
• High Temperature Capability (43–45°C)

Segment by Application

• Colorectal Cancer
• Ovarian Cancer
• Gastric Cancer
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Hyperthermic Intraperitoneal Chemotherapy Equipment market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Colorectal Cancer, Ovarian Cancer, Gastric Cancer evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact